Related Experiment Video
Updated: May 22, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Diagnosis and management of chronic graft-versus-host disease
Fiona L Dignan1, Persis Amrolia, Andrew Clark
1Section of Haemato-oncology, The Royal Marsden NHS Foundation Trust, London, UK.
Insights
This guideline provides recommendations for diagnosing and managing chronic graft-versus-host disease (GvHD). It covers diagnosis, staging, and treatment options, including for steroid-refractory cases, aiming to control GvHD while minimizing risks.
Area of Science:
- Hematology
- Oncology
- Transplantation Immunology
Background:
- Chronic graft-versus-host disease (GvHD) is a significant complication following allogeneic stem cell transplantation.
- Effective management strategies are crucial to improve patient outcomes and quality of life.
Purpose of the Study:
- To develop evidence-based recommendations for the diagnosis and management of chronic GvHD.
- To provide guidance on primary treatment and options for steroid-refractory GvHD.
Main Methods:
- A joint working group from BCSH and BSBMT reviewed existing literature.
- Recommendations were formulated based on the comprehensive literature review.
Main Results:
- The guideline details diagnostic criteria and staging for chronic GvHD.
- It outlines primary treatment approaches and therapeutic options for steroid-refractory disease.
Conclusions:
- The guideline aims to optimize GvHD control.
- Minimizing treatment toxicity and the risk of disease relapse are key objectives.
Abstract:
A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) has reviewed the available literature and made recommendations for the diagnosis and management of chronic graft-versus-host disease (GvHD). This guideline includes recommendations for the diagnosis and staging of chronic GvHD as well as primary treatment and options for patients with steroid-refractory disease. The goal of treatment should be the effective control of GvHD while minimizing the risk of toxicity and relapse.
More Related Videos
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
Related Concept Videos
Cell-mediated Immune Responses
Kidney Transplant III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Chronic Kidney Disease IV: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...